Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Antimicrobial Agents and Chemotherapy|March 13, 2019
Improved Methods for Assessing Therapeutic Potential of Antifungal Agents against Dermatophytes and Their Application in the Development of NP213, a Novel Onychomycosis Therapy CandidateDerry K Mercer, Colin S Stewart, Lorna Miller, et al.
Biochemical and Biophysical Research Communications|August 19, 2023
Cysteamine-mediated blockade of the glycine cleavage system modulates epithelial cell inflammatory and innate immune responses to viral infectionDouglas Fraser-Pitt, Derry K Mercer, Marie-Louise Francis, et al.
Frontiers in Cellular and Infection Microbiology|August 1, 2020
Antimicrobial Susceptibility Testing of Antimicrobial Peptides to Better Predict EfficacyDerry K Mercer, Marcelo D T Torres, Searle S Duay, et al.
ACS Infectious Diseases|June 10, 2021
Antimicrobial Susceptibility Testing of Antimicrobial Peptides Requires New and Standardized Testing StructuresMarita Meurer, Deborah A O'Neil, Emma Lovie, et al.
Infection and Immunity|March 28, 2018
Cysteamine, an Endogenous Aminothiol, and Cystamine, the Disulfide Product of Oxidation, Increase Pseudomonas aeruginosa Sensitivity to Reactive Oxygen and Nitrogen Species and Potentiate Therapeutic Antibiotics against Bacterial InfectionDouglas J Fraser-Pitt, Derry K Mercer, Daniel Smith, et al.
Frontiers in Cellular and Infection Microbiology|October 11, 2021
Cysteamine Inhibits Glycine Utilisation and Disrupts Virulence in <i>Pseudomonas aeruginosa</i>Douglas J Fraser-Pitt, Stephen K Dolan, David Toledo-Aparicio, et al.
Plos One|December 28, 2020
Oral cysteamine as an adjunct treatment in cystic fibrosis pulmonary exacerbations: An exploratory randomized clinical trialGraham Devereux, Danielle Wrolstad, Stephen J Bourke, et al.
Pageof 2